Cargando…

Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials

IMPORTANCE: While wide-scale adoption of durable left ventricular assist devices (LVADs) can be attributed to favorable randomized clinical trial outcomes, restrictive selection criteria may be associated with a lack of generalizability to real-world experience. OBJECTIVE: To estimate the proportion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brescia, Alexander A., Watt, Tessa M. F., Pagani, Francis D., Cascino, Thomas M., Zhang, Min, McCullough, Jeffrey S., Shore, Supriya, Likosky, Donald S., Aaronson, Keith D., Thompson, Michael P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794668/ https://www.ncbi.nlm.nih.gov/pubmed/33416886 http://dx.doi.org/10.1001/jamanetworkopen.2020.32865

Ejemplares similares

Rates and types of infections in left ventricular assist device recipients: A scoping review
por: Pienta, Michael, et al.
Publicado: (2021)

Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers
por: Cascino, Thomas M., et al.
Publicado: (2022)

Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries
por: Cascino, Thomas M., et al.
Publicado: (2022)

Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study
por: Chandanabhumma, P Paul, et al.
Publicado: (2020)

Correction: Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study
por: Chandanabhumma, P Paul, et al.
Publicado: (2022)

Authorship Correction: Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study
por: Chandanabhumma, P Paul, et al.
Publicado: (2020)

Center Variability in Medicare Claims–Based Publicly Reported Transcatheter Aortic Valve Replacement Outcome Measures
por: Thompson, Michael P., et al.
Publicado: (2021)

Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response
por: Tang, Paul C., et al.
Publicado: (2019)

Identifying Temporal Relationships Between In‐Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices
por: Kilic, Arman, et al.
Publicado: (2020)

Safety and Effectiveness of Intravenous Iron Therapy in Patients Supported by Durable Left Ventricular Assist Devices
por: Peters, Carli J., et al.
Publicado: (2022)

Role of the mitral valve in left ventricular assist device pathophysiology
por: Noly, Pierre-Emmanuel, et al.
Publicado: (2022)

Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy
por: Hammer, Yoav, et al.
Publicado: (2023)

Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective
por: Korada, Sai Krishna C., et al.
Publicado: (2020)

The Ineligibility of Antipyrin in Pneumonia
Publicado: (1886)

Commentary: Mending a broken heart: The use of durable mechanical circulatory support
por: Pagani, Francis D.
Publicado: (2021)

6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
por: Wei, Andrew H., et al.
Publicado: (2021)

Determining optimal donor heart ischemic times in adult cardiac transplantation
por: Tang, Paul C., et al.
Publicado: (2022)

Myocardial recovery following durable left ventricular assist device support
por: Rao, Vivek, et al.
Publicado: (2021)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Evaluating treatment-specific post-discharge quality-of-life and cost-effectiveness of TAVR and SAVR: Current practice & future directions
por: Fliegner, Maximilian A., et al.
Publicado: (2021)

Right ventricular lead perforation through the septum, left ventricle, and pleura, managed by an open surgical approach
por: Iribarne, Alexander, et al.
Publicado: (2018)

Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Optimal therapeutic strategy using durable left ventricular assist device in Korea
por: Imamura, Teruhiko
Publicado: (2021)

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
por: Wei, Andrew H., et al.
Publicado: (2021)

Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support
por: SINGH, RAJAT, et al.
Publicado: (2020)

Using machine learning to improve risk prediction in durable left ventricular assist devices
por: Kilic, Arman, et al.
Publicado: (2021)

Intra‐Aortic Balloon Pump as a Bridge to Durable Left Ventricular Assist Device
por: Brown, Matthew A., et al.
Publicado: (2021)

Rescue extracorporeal life support as a bridge to durable left ventricular assist device
por: Zubarevich, Alina, et al.
Publicado: (2021)

Key questions about aortic insufficiency in patients with durable left ventricular assist devices
por: Calin, Eliza, et al.
Publicado: (2022)

Durable Left Ventricular Assist Device Outflow Graft Obstructions: Clinical Characteristics and Outcomes
por: Peters, Carli J., et al.
Publicado: (2023)

Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
por: Wintgens, L. I. S., et al.
Publicado: (2019)

Removal of ineligible outcome cases reduces confounding
por: Walker, Alexander M, et al.
Publicado: (2018)

Bail-out Ablation of Ventricular Tachycardia Electrical Storm in a Patient with a Durable Left Ventricular Assist Device
por: Izumida, Toshihide, et al.
Publicado: (2022)

To VAD or Not to VAD: A Case of Durable Left Ventricular Assist Device Implantation in a COVID-19 Patient
por: Ignaszewski, M., et al.
Publicado: (2021)

The First Pediatric Heart Transplantation Bridged by a Durable Left Ventricular Assist Device in Korea
por: Shin, Jung Hoon, et al.
Publicado: (2020)

Re‐Thinking Re‐Synching in Left Ventricular Assist Device Recipients
por: Vader, Justin M., et al.
Publicado: (2018)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement
por: Hatab, Taha, et al.
Publicado: (2023)

Beyond abstraction: applying the brakes to runaway patent ineligibility
por: Burk, Dan L.
Publicado: (2016)

Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
por: Shah, Sachin P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ca1qv2vnvvb2kq8fl9rdv5gi79